🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsATTAIN-2: orforglipron in T2DM — glycemic endpoints Page 4

ATTAIN-2: orforglipron in T2DM — glycemic endpoints

TrialTracker_MD Mon, May 25, 2026 at 5:34 AM 23 replies 549 viewsPage 4 of 5
sophie_paris
Member
212
890
Nov 2024
Paris, FR
May 28, 2026 at 5:43 PM#16
LibrarianMeg said:
It is worth asking what the claim would look like if it were false.

Same experience, arrived at from the opposite direction. Posting only so the count is not one.

26 24SallyK_inj, CryptoCarl, MariaRD and 23 others
Reply Quote Save Share Report
LondonLisa
Member
912
3,456
Mar 2024
London, UK
May 29, 2026 at 5:27 AM#17
Dr.GutHealth said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Can confirm. Same sequence, different timescale. The detail I would add is minor and it is already implied above.

27 0Dr.MetabolicMD, RetaRick_CA, JenPlateau and 24 others
Reply Quote Save Share Report
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
May 29, 2026 at 5:10 PM#18
Dr.GutHealth said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Coming at Dr.GutHealth’s question from a different direction. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Last edited: May 29, 2026 at 8:10 PM
28 1amsterdam_pete, LondonLisa, mike_nyc and 25 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
May 30, 2026 at 4:54 AM#19

Adding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

29 2B12Beth, RickReta_CO, PharmHunterJen and 26 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 30, 2026 at 4:38 PM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. No action needed from anybody.

1 24PeptideSynthNJ
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register